2018 annual financial data

TG Therapeutics 2018 Financial results

Direct answer

Revenue was 152,000 USD.

Operating income was -174,400,000 USD and net income was -173,482,000 USD.
Operating cash flow was -128,925,000 USD.

Get free TG Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
152,000 USD
Operating income
-174,400,000 USD
Net income
-173,482,000 USD
Operating cash flow
-128,925,000 USD